Payment overview · 2025
General Payments
$117.15
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jesus R Amparo
Allopathic & Osteopathic Physicians|Internal Medicine · BAYAMON, PR · NPI 1376514653
Verified facts
What the public records show
CMS Open Payments records show Jesus R Amparo received $117.15 in general payments during 2025 across 1 reported records.
Terumo Medical Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $117.15 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $117.15 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ACCESS Normalized: access |
Device | Terumo Medical Corporation | $117.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 929 | 339 |
| Losartan Potassium | Losartan Potassium | 641 | 203 |
| Gabapentin | Gabapentin | 624 | 152 |
| Famotidine | Famotidine | 590 | 279 |
| Amlodipine Besylate | Amlodipine Besylate | 587 | 178 |
| Synthroid | Levothyroxine Sodium | 534 | 92 |
| Metoprolol Succinate | Metoprolol Succinate | 512 | 191 |
| Pantoprazole Sodium | Pantoprazole Sodium | 494 | 176 |
| Metformin Hcl | Metformin Hcl | 420 | 100 |
| Simvastatin | Simvastatin | 335 | 98 |
| Levothyroxine Sodium | Levothyroxine Sodium | 319 | 124 |
| Alendronate Sodium | Alendronate Sodium | 306 | 65 |
| Clopidogrel | Clopidogrel Bisulfate | 267 | 131 |
| Omeprazole | Omeprazole | 253 | 66 |
| Lisinopril | Lisinopril | 252 | 80 |
| Glimepiride | Glimepiride | 239 | 53 |
| Eliquis | Apixaban | 235 | 109 |
| Irbesartan | Irbesartan | 229 | 69 |
| Furosemide | Furosemide | 228 | 111 |
| Montelukast Sodium | Montelukast Sodium | 224 | 87 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 221 | 92 |
| Tamsulosin Hcl | Tamsulosin Hcl | 194 | 74 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 162 | 61 |
| Sertraline Hcl | Sertraline Hcl | 151 | 50 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 148 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 145 | 44 |
| Meloxicam | Meloxicam | 140 | 60 |
| Nifedipine Er | Nifedipine | 140 | 60 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 138 | 31 |
| Allopurinol | Allopurinol | 121 | 33 |
| Levofloxacin | Levofloxacin | 120 | 114 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 119 | 113 |
| Enalapril Maleate | Enalapril Maleate | 116 | 31 |
| Carvedilol | Carvedilol | 115 | 46 |
| Fenofibrate | Fenofibrate | 109 | 36 |
| Doxazosin Mesylate | Doxazosin Mesylate | 98 | 31 |
| Donepezil Hcl | Donepezil Hcl | 85 | 29 |
| Glipizide | Glipizide | 85 | 28 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 80 | 37 |
| Spironolactone | Spironolactone | 77 | 36 |
| Fluticasone Propionate | Fluticasone Propionate | 76 | 32 |
| Xarelto | Rivaroxaban | 74 | 30 |
| Diclofenac Potassium | Diclofenac Potassium | 73 | 28 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 73 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 71 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 67 | 36 |
| Farxiga | Dapagliflozin Propanediol | 65 | 24 |
| Memantine Hcl | Memantine Hcl | 63 | 13 |
| Finasteride | Finasteride | 62 | 20 |
| Clonazepam | Clonazepam | 60 | 26 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 58 | 23 |
| Meclizine Hcl | Meclizine Hcl | 58 | 26 |
| Cilostazol | Cilostazol | 57 | 13 |
| Hydralazine Hcl | Hydralazine Hcl | 56 | 41 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 55 | 52 |
| Azithromycin | Azithromycin | 54 | 52 |
| Januvia | Sitagliptin Phosphate | 54 | 12 |
| Humalog | Insulin Lispro | 52 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 51 | 30 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 51 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 50 | 11 |
| Nabumetone | Nabumetone | 49 | 21 |
| Candesartan Cilexetil | Candesartan Cilexetil | 47 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 47 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 47 | 14 |
| Atenolol | Atenolol | 46 | 13 |
| Baclofen | Baclofen | 44 | suppressed |
| Brilinta | Ticagrelor | 44 | 19 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 43 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | suppressed |
| Cefaclor | Cefaclor | 41 | 40 |
| Diclofenac Sodium | Diclofenac Sodium | 38 | 11 |
| Valsartan | Valsartan | 38 | 20 |
| Glipizide Er | Glipizide | 37 | 13 |
| Entresto | Sacubitril/Valsartan | 36 | suppressed |
| Verapamil Er | Verapamil Hcl | 36 | suppressed |
| Temazepam | Temazepam | 35 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 34 | 16 |
| Mirtazapine | Mirtazapine | 33 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 32 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 31 | suppressed |
| Methylprednisolone | Methylprednisolone | 31 | 27 |
| Pentoxifylline | Pentoxifylline | 31 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 30 | suppressed |
| Prednisone | Prednisone | 30 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 29 | 29 |
| Levetiracetam | Levetiracetam | 29 | 15 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 28 | suppressed |
| Fluconazole | Fluconazole | 28 | 25 |
| Gemfibrozil | Gemfibrozil | 28 | 12 |
| Ibandronate Sodium | Ibandronate Sodium | 28 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 28 | 27 |
| Jentadueto | Linagliptin/Metformin Hcl | 27 | suppressed |
| Naproxen | Naproxen | 27 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Insulin Lispro | Insulin Lispro | 26 | 17 |
| Sucralfate | Sucralfate | 26 | 17 |
| Humulin N | Insulin Nph Human Isophane | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Folic Acid | Folic Acid | 24 | 13 |
| Diltiazem Hcl | Diltiazem Hcl | 23 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 22 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 22 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Latanoprost | Latanoprost | 21 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 21 | 13 |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Tradjenta | Linagliptin | 20 | suppressed |
| Lactulose | Lactulose | 19 | 19 |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 19 | 17 |
| Pregabalin | Pregabalin | 19 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 18 | suppressed |
| Ramipril | Ramipril | 18 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Insulin Glargine | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 16 |
| Alprazolam | Alprazolam | 16 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 16 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Enulose | Lactulose | 16 | 12 |
| Ezetimibe | Ezetimibe | 16 | suppressed |
| Jardiance | Empagliflozin | 16 | suppressed |
| Lansoprazole | Lansoprazole | 16 | suppressed |
| Methimazole | Methimazole | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 14 |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Phenobarbital | Phenobarbital | 14 | suppressed |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 13 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 13 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Dipyridamole | Dipyridamole | 12 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 12 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 12 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Sure Comfort | Syring-Needl,disp,insul,0.3 Ml | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Calcium Acetate | Calcium Acetate | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Potassium Chloride | Potassium Chloride | 11 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $117.15 · 1 records | Terumo Medical Corporation | ACCESS | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error